In Vitro Diagnostics: World Market Outlook 2011-2021 - Can This Market Achieve Growth?

NEW YORK, Aug. 3, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

In Vitro Diagnostics: World Market Outlook 2011-2021 - Can this market achieve growth?

http://www.reportlinker.com/p0578540/In-Vitro-Diagnostics-World-Market-Outlook-2011-2021---Can-this-market-achieve-growth.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

How will the in vitro diagnostics (IVD) market develop this decade? Our report shows you potential revenues to 2021, discussing opportunities and prospects. Through our research and analysis we aim to save you time and help in your decisions.

Our new study shows you potential revenues to 2021 for in vitro diagnostics at total world, submarket and national levels. What technologies and applications will expand that market? What effects will changes have? You will find predictions and answers.

In our report you will find revenue predictions for clinical chemistry, immunochemistry, haematology, microbiological culture, genetic testing, immunotechnology, point of care testing (POCT) and laboratory testing.

You will find coverage of Roche, Siemens, Abbott Laboratories, Beckman Coulter and Becton, Dickinson and Company. We also discuss Quest Diagnostics, Laboratory Corporation of America and other companies in the medical diagnostics market.

Our study predicts future trends. You will find analyses of IVD applications in diabetes, oncology, infectious diseases, cardiovascular disorders, drug abuse and fertility testing.

We help you to assess the in vitro diagnostics industry and market's strengths, weaknesses, trends and potential revenues to 2021. You will see where those technologies are heading.

Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.

Original analysis with revenues, growth rates, market shares, opinion and discussions 

You will find revenue forecasts, growth rates, market shares, a SWOT/STEP review, opinions from our survey and discussions of technologies and companies. We provide 98 tables and charts and two research interviews (shown in the accompanying lists).

In Vitro Diagnostics: World Market Outlook 2011-2021 shows you opportunities, challenges and revenue forecasts

Our report gives you the following advantages:

• You will discover revenue forecasts to 2021 for the world in vitro diagnostics market and its main components, seeing where the highest revenue growth will occur

• You will find revenue forecasts to 2021 for IVD technologies, assessing their commercial potential and applications

• You will discover revenue forecasts to 2021 for leading national markets (US, Japan, Germany, France, Spain, UK, Italy, China and India), seeing growth trends

• You will assess leading companies in IVD, discovering their activities and outlooks 

• You will investigate competition and opportunities influencing the IVD industry and market from 2011 onwards

• You will see what will stimulate and restrain the IVD industry and market from 2011

• You will identify diagnostic needs and commercial opportunities, including those for personalised medicine

• You will examine emerging medical diagnostic technologies, including theranostics, seeing opportunities and revenue potential

• You will analyse opportunities and challenges for established companies and those seeking to enter the IVD and personalised medicine market

• You will view opinions from our industry survey, receiving full interview transcripts.

That mix of quantitative and qualitative analysis sets our report apart. We tackle crucial questions in the in vitro diagnostics industry and market, aiming to save you time and effort.

Order our report now to gain industry and market analysis for medical diagnostic tests

Our report is for everybody interested in market analysis, product development, sales and marketing for diagnostic tests and devices. You will find predictions and answers. Don't miss out – please order our report now.

Visiongain is a trading partner with the US Federal Government

CCR Ref number: KD4R6

NB: All visiongain reports are password locked so please let us know what licence is most suitable for your business needs

Table of Contents

1. Executive Summary

1.1 Overview of the In Vitro Diagnostics World Market, 2011-2021

1.2 The Scope of this Report

1.3 Chapter Outlines

1.4 Research and Analysis Methods

2. Introduction to the In Vitro Diagnostics Industry

2.1 What are In Vitro Diagnostic (IVD) Tests?

2.2 Classifying IVD: EDMA Classification

2.2.1 Clinical Chemistry

2.2.2 Immunochemistry

2.2.3 Haematology

2.2.4 Microbiology

2.2.5 Genetic Testing

2.3 Classifying IVD: Disease Areas

2.4 Regulatory Issues in the IVD Market

2.4.1 FDA Classifications

2.4.2 Regulation of IVD Tests

2.5 Types of IVD Tests

2.6 Personalised Medicine: Pharmacogenomics, Pharmacogenetics, Theranostics and Proteomics

2.6.1 Pharmacogenomics

2.6.2 Proteonomics

2.7 Sensitivity and Specificity

3. The Global In Vitro Diagnostics Market, 2011-2021

3.1 The Global IVD Market in 2009

3.2 Global IVD Market Forecast, 2011-2021

3.3 Global IVD Market Forecasts by EDMA Category, 2011-2021

3.3.1 Clinical Chemistry Market Forecast, 2011-2021

3.3.2 Immunochemistry Market Forecast, 2011-2021

3.3.3 Haematology Market Forecast, 2011-2021

3.3.4 Microbiology (Culture) Market Forecast, 2011-2021

3.3.5 Immunotechnology for Infectious Diseases Market Forecast, 2011-2021

3.3.6 Genetic Testing Market Forecast, 2011-2021

3.3.7 Cytogenetic Tests: FISH (Fluorescence In-Situ Hybridisation)

3.3.7.1 What is FISH?

3.3.7.2 Cytogenetics and FISH Will Drive Growth in the Genetic Testing Market

3.4 Point-of-Care Testing Market Forecast, 2011-2021

3.5 Laboratory Testing Market Forecast, 2011-2021

4. In Vitro Diagnostics: Leading National Markets, 2011-2021 

4.1 Leading National Markets for IVD Tests in 2010

4.2 The US IVD Market: Forecast and Outlook, 2011-2021

4.3 The Japanese IVD Market: Forecast and Outlook, 2011-2021

4.4 Leading European IVD Markets: Forecasts and Outlook, 2011-2021

4.4.1 The German IVD Market, 2011-2021 

4.4.2 The French IVD Market, 2011-2021

4.4.3 The Italian IVD Market, 2011-2021 

4.4.4 The Spanish IVD Market, 2011-2021

4.4.5 The UK IVD Market, 2011-2021

4.5 Top 5 EU Markets, 2011-2021

4.6 Chinese IVD Market: Forecast and Outlook, 2011-2021

4.7 Indian IVD Market: Forecast and Outlook, 2011-2021

4.8 IVD Revenues from Leading Emerging Markets, 2011-2021

4.9 Revenues in the Rest of the World, 2011-2021

4.10 Global IVD Market by Region, 2010

5. Important Therapy Areas for IVD Tests

5.1 Diabetes

5.2 Oncology

5.3 Infectious Disease

5.3.1 Hospital-Acquired Infections

5.3.2 HIV 

5.3.3 Tuberculosis

5.3.3.1 Skin Tests

5.3.3.2 Smear Microscopy

5.3.3.3 Microbiological Culture

5.3.3.4 Nucleic Acid Based Testing

5.3.3.5 Immunoassays

5.3.3.6 Phage Assay

5.4 Influenza

5.5 Reproductive Tests

5.6 Drug Abuse

5.6.1 Drugs Commonly Tested For 

5.6.2 Types of Samples

5.7 Cardiovascular Disease

5.7.1 Cardiac Markers

5.7.2 Cholesterol Screening

6. Leading Companies in the IVD Industry and Market

6.1 Top 5 IVD Manufacturers

6.2 Roche

6.3 Siemens AG

6.4 Abbott Laboratories

6.5 Beckman Coulter

6.6 Becton Dickinson

6.7 Laboratory Services

6.7.1 Quest Diagnostics

6.7.2 Laboratory Corporation of America

6.7.3 Direct-to-Consumer Genomic Testing Companies

7. Theranostics and Personalised Medicine, 2011-2021

7.1 What is Personalised Medicine?

7.2 Maximising Benefits to Healthcare Stakeholders

7.3 Minimising Harm

7.4 Increasing Compliance

7.5 Streamlining Clinical Trials

7.6 Reviving Failed or Withdrawn Drugs

7.7 Reducing the Costs of Healthcare

7.8 Shifting from Reaction to Prevention

7.9 What is Required for Personalised Medicine to Become Widespread?

7.9.1 The Cost of Genomic Sequencing Must Fall

7.9.2 Large Scale Studies and Databases

7.9.3 A Healthcare IT Infrastructure that Integrates Clinical Data and Other Research

7.9.4 Medical Education

7.9.5 Guaranteed Reimbursements

7.10 Theranostics Forecast, 2011-2021

8. Drivers and Restraints in the IVD Industry and Market, 2011-2021

8.1 SWOT Analysis of the IVD Market Area

8.2 Factors Driving Growth of the IVD Market

8.3 Factors Restraining Growth of the IVD Market

9. Opinions from Our Industry Survey

9.1 Godwin Liu, Marketing Manager, Shenzhen Mindray Bio-Medical Electronics Co.

9.1.1 About Mindray

9.1.2 Unmet Needs in the IVD Market

9.1.3 Growth in the IVD Sector

9.1.4 Challenges Faced by the IVD Market

9.1.5 Market Expansion for IVD Products

9.2 Interview 2: Director of a Diagnostics Company

9.2.1 Most-Promising Therapeutic Areas for IVD

9.2.2 Unmet Medical Needs in IVD

9.2.3 Greatest Obstacles to Market Growth

9.2.4 Prospects for IVD Market Growth in Developing Countries

9.2.5 Prospects for Theranostics

10. Conclusions

10.1 In Vitro Diagnostics are Vital to Clinical Decision Making

10.2 Significant Growth of In Vitro Diagnostics Market from 2010 to 2021

10.3 The Top Five Manufacturers Command the Majority of the IVD Market

10.4 Expansion of the World Market Boosted by Rising Revenues in the Developing Healthcare Markets

10.5 IVD Solutions are the Cornerstone of Personalised Medicine

10.6 Concluding Thoughts on this Expanding Industry and Market

List of Tables

Table 3.1 World Revenues ($bn) and Market Shares (%) by Sub Market, 2010, 2015 and 2021

Table 3.2 Global IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 3.3 Global IVD Market Forecast by Sub Market ($bn, AGR%, CAGR %), 2009-2021 

Table 3.4 World Clinical Chemistry Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 3.5 Automated Sample Analysers, 2011

Table 3.6 World Immunochemistry Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 3.7 Immunochemistry IVD Applications, 2010

Table 3.8 World Haematology Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 3.9 Haematology IVD Applications, 2011

Table 3.10 World Microbiology Culture Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 3.11 World Infectious Immunology Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 3.12 World Genetic Testing Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 3.13 Genetic Testing IVD Applications, 2011

Table 3.14 World POCT Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 3.15 World Laboratory Testing Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 3.16 Revenues ($bn) for Laboratory Testing and POCT, 2010

Table 3.17 POCT and Laboratory Testing Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 4.1 Leading National Markets for IVD ($bn, %), 2010, 2015 and 2021

Table 4.2 US IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 4.3 Japanese IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 4.4 German IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 4.5 French IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 4.6 Italian IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 4.7 Spanish IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 4.8 UK IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 4.9 Top 5 EU IVD Market Forecasts ($bn, AGR%, CAGR %), 2009-2021 

Table 4.10 Chinese IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 4.11 Indian IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021 

Table 4.12 Indian and Chinese IVD Market Forecasts ($bn, AGR%, CAGR %), 2009-2021 

Table 4.13 IVD Market Forecast for the Rest of the World ($bn, AGR%, CAGR %), 2009-2021 

Table 4.14 Leading National Markets for IVD: Revenue Forecasts ($bn), 2009-2021

Table 4.15 World IVD Market: Regional Revenues ($bn), 2010

Table 5.1 Main Therapy Areas for IVD Testing ($bn, %), 2010

Table 5.2 Diabetes IVD Test Revenues ($bn) and Market Shares (%), 2010

Table 5.3 Oncology IVD Test Revenues ($bn) and Market Shares (%), 2010

Table 5.4 Theranostics for Oncology, 2011

Table 5.5 Infectious Immunology IVD Market Revenues ($bn) and Market Shares (%) by Technology, 2010

Table 5.6 Infectious Immunology Revenues ($bn) and Market Shares (%) by Disease, 2010

Table 5.7 HIV IVD Market Revenues ($bn) and Market Shares (%) by Application, 2010

Table 5.8 TB Diagnostics Revenues ($m) and Market Shares (%), 2010

Table 5.9 Male and Female Fertility Markers, 2011

Table 5.10 Cardiovascular IVD Market Revenues ($bn) and Market Shares (%), 2010

Table 5.11 Cardiac Markers, 2011

Table 5.12 Cardiac IVD Market by Test Type ($bn, %), 2010

Table 6.1 IVD Revenues ($bn) from Leading Companies, 2010

Table 6.2 Roche Diagnostics Revenues ($m), 2010

Table 6.3 Siemens Healthcare Revenues ($m), 2010

Table 6.4 Abbott Laboratories Revenues ($m) for Diagnostics, 2010

Table 6.5 Beckman Coulter Revenues ($m), 2010

Table 6.6 Becton Dickinson Diagnostics Revenues ($m), 2010

Table 6.7 Quest Diagnostics Revenues ($m), 2009

Table 6.8 LabCorp Diagnostics Revenues ($m), 2009

Table 6.9 Conditions Tested for by 23and Me, 2010

Table 7.1 Differences between Traditional and Personalised Medicine

Table 7.2 Average Response Rates to Treatment for Various Diseases, 2010

Table 7.3 Drugs Metabolised by CYP450: 2C19 and 2D6, 2011

Table 7.4 Diagnostics and Theranostics Forecasts ($bn), 2009-2021

Table 8.1 SWOT Analysis of the Global IVD Market, 2011-2021

List of Figures

Figure 3.1 World Market Shares (%) by Sub Market, 2010

Figure 3.2 World Market Shares (%) by Sub Market, 2015

Figure 3.3 World Market Shares (%) by Sub Market, 2021

Figure 3.4 Global IVD Market Forecast ($bn), 2009-2021 

Figure 3.5 World Clinical Chemistry Market Forecast ($bn), 2009-2021 

Figure 3.6 World Immunochemistry Market Forecast ($bn), 2009-2021 

Figure 3.7 World Haematology Market Forecast ($bn), 2009-2021 

Figure 3.8 World Microbiology Culture Market Forecast ($bn), 2009-2021 

Figure 3.9 World Infectious Immunology Market Forecast ($bn), 2009-2021 

Figure 3.10 World Genetic Testing Market Forecast ($bn), 2009-2021 

Figure 3.11 World IVD Market Forecast with Sub Markets ($bn), 2009-2021 

Figure 3.12 World Point of Care Testing (POCT) Market Forecast ($bn), 2009-2021 

Figure 3.13 World Laboratory Testing Market Forecast ($bn), 2009-2021 

Figure 3.14 Market Shares (%): Laboratory Testing and POCT, 2010

Figure 4.1 Leading National Market Shares (%) for IVD, 2010

Figure 4.2 Leading National Market Shares (%) for IVD, 2015

Figure 4.3 Leading National Market Shares (%) for IVD, 2021

Figure 4.4 US IVD Market Forecast ($bn), 2009-2021

Figure 4.5 Japanese IVD Market Forecast ($bn), 2009-2021

Figure 4.6 US and Japanese IVD Market Forecasts ($bn), 2009-2021

Figure 4.7 Top 5 EU IVD Market Forecasts ($bn), 2009-2021

Figure 4.8 Indian and Chinese IVD Market Forecasts ($bn), 2009-2021

Figure 4.9 IVD Market Forecast ($bn) for the Rest of the World, 2009-2021

Figure 4.10 Leading National Markets for IVD: Revenue Forecasts ($bn), 2009-2021

Figure 4.11 World IVD Market: Regional Market Shares (%), 2010

Figure 5.1 World Market Shares (%) for Major Therapy Areas for IVD Tests, 2010

Figure 5.2 Diabetes IVD Market Shares (%), 2010

Figure 5.3 Oncology IVD Market Shares (%), 2010

Figure 5.4 Infectious Immunology IVD Market Shares (%), 2010

Figure 5.5 US Infectious Immunology IVD Market Shares by Disease (%), 2010

Figure 5.6 HIV IVD Market Shares by Application (%), 2010

Figure 5.7 TB Diagnostics Market Shares (%), 2010

Figure 5.8 Cardiovascular Diagnostics Market Shares (%), 2010

Figure 5.9 Cardiac IVD Market by Test Type (%), 2010

Figure 6.1 Market Shares (%) of Leading Companies for IVD, 2010

Figure 6.2 Quest Diagnostics Revenue Shares (%) by Sector, 2009

Figure 6.3 LabCorp Diagnostics Revenue Shares (%), 2009

Figure 7.1 Average Response Rates for Various Diseases, 2011

Figure 7.2 Theranostics Market Forecast ($bn), 2009-2021

Figure 7.3 Diagnostics and Theranostics: Revenue Forecasts ($bn), 2009-2021

Companies Listed

23andMe

Abbott Laboratories

AmeriPath

Axis-Shield

Beckman Coulter

Becton, Dickinson and Company

BIOTEC Laboratories

bioTheranostics

Cellestis

Center for Disease Control and Prevention (CDC)

Clinical Data

Complete Genomics

Dade Behring

Dianon Systems

Duke University

Dynacare Laboratories

Enterix

EntroGen

Esoterix

European Diagnostic Manufacturers Association (EDMA)

European Medicines Evaluation Agency (EMEA)

Focus Diagnostics

Food and Drug Administration (US FDA)

Genetics & Public Policy Center

HemoCue

Hologic

Home Access Health

Laboratory Corporation of America

Litholink Corporation

Modern Health Systems

Monogram Biosciences

Myriad Genetics

National Genetics Institute

National Health Service (UK NHS)

Navigenics

OraSure Technologies

Oxford Immunotec

ParagonDx

Pathway Genomics

Pfizer

Prometheus

Qiagen

Quest Diagnostics

Radient Pharmaceuticals

Roche

Shenzhen Mindray Bio-Medical Electronics Co. (Mindray)

Siemens

State Food and Drug Administration (SFDA, China)

US LABS

Vermillion Diagnostics

ViroMed Laboratories

Walgreens

Warner-Chilcott

World Health Organization (WHO)

To order this report:

In Vitro Diagnostic Industry: In Vitro Diagnostics: World Market Outlook 2011-2021 - Can this market achieve growth?

In Vitro Diagnostic Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker